reported frequent readmissions, seen as high as one in five patients with AECOPD (Jencks, Williams, & Coleman, 2009 ).
The primary aim of AECOPD treatment was to minimize the clinical impact of the current exacerbation and to prevent subsequent deterioration events that may include readmission (Crisafulli, Barbeta, Ielpo, & Torres, 2018) . Published AECOPD treatment guidelines exist (GOLD, 2019; NICE, 2018) although adherence has been found to be challenging (Lodewijck et al., 2009 ) with clinician-reported barriers including poor familiarity with recommendations, low self-efficacy and time constraints (Perez, Wisniveskya, Lurslurchachai, Kleinman, & Kronish, 2012) . A pan-European audit of the largest dataset of prospectively collected, real-world AECOPD quality of care and outcomes data underscored gaps in quality of care in many European countries when compared with evidence-based recommendations (Hartl et al., 2016 ). An NHS audit further highlighted wide variation in treatment provision and outcomes for patients admitted with AECOPD (Royal College of Physicians (UK), 2017).
In Ireland, COPD is one of the most common respiratory diseases, placing a significant burden of disease on people and health services as evidenced by mortality and hospitalization rates (Irish Thoracic Society, 2018) . Having the highest hospitalization rate for COPD among selected OECD countries (DOH, 2018), recommendations have been made for the Irish healthcare service to focus on strategies which aim to reduce avoidable emergency admissions for cases that could be managed in a primary care or home setting (OECD, 2016) .
To address these issues, Ireland is currently undertaking steps towards expansion of an integrated model of care for chronic diseases including COPD. Furthermore, there is now an opportunity to improve aspects of care for AECOPD in Irish acute hospital settings through a commissioned COPD QI intervention to focus on the acknowledged issue of high rates of presentation, admission and length of stay in Irish hospitals for people with AECOPD. Findings of this review will inform the development of an evidence-based QI intervention in secondary care in AECOPD care aimed to reduce unnecessary or avoidable admissions and readmissions.
| Research question
What QI interventions have been reported to standardize care or reduce unnecessary admission or readmissions in AECOPD?
| THE S TUDY

| Design
A scoping review methodology will be used to conduct this study.
Unlike a systematic review, a scoping review aims for breadth and comprehensiveness, rather than depth (Arksey & O'Malley, 2005) . The aim of a scoping review was to generate an overview of research undertaken on a topic and determine the range of studies that are available, summarize research results and identify evidence gaps (Wickremasinghe, Kuruvilla, Mays, & Avan, 2016 ). This protocol is prepared to guide the performance of the scoping review which will be undertaken and will be revised as needed. The protocol and review design will follow methodologies proposed by Arksey and O'Malley (2005) , Levac, Colquhoun, & O'Brien, 2010 , The Joanna Briggs Institute (2015 and PRISMA-P guidelines (Tricco et. al., 2018) . The review will follow the five prescribed steps of a scoping review with the sixth, optional stage-consultation with stakeholders-not deemed relevant in this instance. Stage 1 involves development of the research question. Definition of eligibility criteria and search strategy are then completed in stage 2. In stage 3, the study selection process based on the eligibility criteria occurs. During stage 4, a data extraction framework will be developed to inform the extraction and charting of data from the included papers. Finally, data extraction results will be aggregated and summarized.
| Method
The search strategy is designed to be as extensive as possible to identify all possible eligible studies, which will be then refined according to the inclusion and exclusion criteria. The scoping review will include published primary data that can be retrieved from the following electronic databases: Web of Science, EMBASE (Elsevier) and PUBMED. The reference lists from included studies will be screened to ensure literature saturation. Reference lists of reviews found through the electronic search will be checked to ensure that relevant articles are included in the scoping review.
Studies to be included will meet the following eligibility criteria:
• Peer-reviewed, primary evidence, journal articles, published be- The following studies will be excluded:
• Studies which refer to aetiology, physiology, environmental fac- Duplicate records will be removed and then three reviewers will independently screen all titles for relevance. Following this, abstract screening will be undertaken independently by two reviewers with any discrepancies to be resolved by discussion and consensus with a third reviewer. Finally, full texts will be assessed by one reviewer against the inclusion criteria and independently by a panel of expert reviewers [in the field of respiratory medicine, nursing and academia] before a final decision regarding inclusion/exclusion will be confirmed.
Any discrepancies will be resolved by discussion and consensus with a second reviewer. Reasons for excluding studies will be noted.
A data extraction template will be used to chart data from each included article. One researcher will read each article and extract relevant data. Charting will be iteratively conducted; additional categories may be identified through completion of the search and communication with review team members. One additional author will test the extraction list by applying it to 10% of studies selected randomly from the pool of studies included for full-text screening.
Based on this test, items will be added or removed, to ensure the comprehensiveness of the list.
The data extraction form will include at least the following items: 
| Analysis
The data arising from this review will be collated and summarized quantitatively (using a simple numerical count) and qualitatively (drawing on narrative/thematic synthesis), seeking evidence for 
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